Rea, Federico
Morabito, Gabriella
Corrao, Giovanni
Cantarutti, Anna
Funding for this research was provided by:
Università degli Studi di Milano-Bicocca (2023-ATEQC-0069)
Article History
Received: 18 December 2023
Accepted: 29 October 2024
First Online: 9 November 2024
Declarations
:
: Not applicable.
: Not applicable.
: Giovanni Corrao received research support from the European Community (EC), the Italian Medicines Agency (AIFA), Italian Ministry of Health, and the Italian Ministry of Education, University and Research (MIUR). He took part to a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN, BMS, and Servier). He also received honoraria from Roche as a member of its Advisory Board. Other authors have no disclosures.